Alpha-1 Antitrypsin Deficiency: A Review for Nurse Practitioners

Instructor:  ExcelCME
Course Dates: January 2, 2018 - January 2, 2020
Enrollment Dates: Enroll Anytime
Who can Enroll: Anyone
Course Language: English
Price:  FREE

About the Course

Alpha-1 Antitrypsin Deficiency: A Review for Nurse Practitioners

Credits: 1 Nursing contact hour

Accredited Provider: Maryland Nurses Association is an accredited approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Commercial Supporters: This educational initiative is supported by the Alpha-1 Foundation

Course Description: 

Alpha-1 Antitrypsin Deficiency (Alpha-1) is a common genetic disease that is underrecognized, underdiagnosed and often misdiagnosed as COPD or asthma.  It can cause liver and lung disease. The liver makes a protein called Alpha-1 Antitrypsin that goes into the bloodstream. This protein protects the lungs and allows them to work normally. If there is not enough Alpha-1 Antitrypsin, it is called Alpha-1 Antitrypsin Deficiency.  Although Alpha-1 is one of the most common genetic life-threatening diseases worldwide, with an incidence comparable to that of cystic fibrosis, it remains underrecognized and undertreated and therefore continues to pose a significant health threat.  According to the Alpha-1 Foundation, it is estimated that 1 in every 2,500 Americans have Alpha-1 yet less than 10% have been diagnosed. This exemplifies a significant healthcare knowledge gap.  Many nurses have suboptimal knowledge/awareness of this genetic disorder and easily misdiagnose it for asthma or COPD, leading to an increased risk of patient mortality.  This on-demand accredited activity intends to close knowledge gaps by increasing awareness regarding Alpha-1, which is paramount to increasing the number of identified carriers, provide strategies for diagnosing and treating these patients, therefore preventing further damage to improve patient outcomes and prolong their life span.

Intended Audience: 

This educational initiative is designed for general practice nurses and nurse practitioners.

Educational Objectives:

After this educational activity, you should be able to:

  • Recognize the different clinical manifestations of Alpha-1 Antitrypsin Deficiency
  • Improve your understanding of the disease and the genetic background of the disorder
  • Examine the data supporting augmentation therapy and how to manage these patients
  • List the nurse’s role in overcoming nonadherence using communication techniques that may positively impact patient compliance
  • Apply the use of key teaching strategies when educating patients newly diagnosed with Alpha-1 Antitrypsin Deficiency.

Faculty:

James Stoller, MD, MS

Conflicts of Interest: 

DISCLOSURES

Presenter:  James Stoller, MD, MS.  Dr. Stoller is a scientific consultant for Talecris, CSL Behring, Boehringer-Ingelheim, Arrowhead Pharmaceuticals, AsthmaTX, Kamada, 23andMe, and Pfizer. His speaking engagements have been sponsored by Talecris, CSL Behring, Baxter, and Grifols.

Nurse Planner:  Debbie Waldrop, MSN, RN, CCRC has no relevant financial information to disclose.

Peer Reviewer:  Adam Wanner, MD has indicated that he serves as a consultant for Grifols and Plasma Protein Manufacturing. 

Kathy Welch, Manager of Program Administration for Alpha-1 Foundation, and EXCEL staff have no relevant financial information to disclose.

Accreditation Statement:

The Maryland Nurses Association is an accredited approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Instructions:

Once you have completed the activity, please click the "next" button to advance to the post-activity assessment. To complete this activity and claim credit, you must answer 3 out of the 4 questions correctly. If you are not successful after your first attempt, you will be given an opportunity to reflect upon the answer rationales and can once again review the educational content before proceeding. Once you have selected your answers, click the "submit" button to complete the evaluation questions and proceed to the claim credit screen.

To obtain a certificate, participants must enter a response to all questions in the post-lecture evaluation and must write a brief self-reflective statement as indicated at the end of the evaluation. The evaluation and directions for the self-reflective statement can be accessed at the end of the activity. your online certificate will be saved on PureCME within your account, which you can access at any time.

If you have any questions relating to the accreditation of this activity, please contact kwelch@alpha1.org.

Disclaimer: The opinions expressed in this educational activity are those of the faculty, and do not represent those of the content creators. This activity is meant to supplement existing knowledge, published information, and practice guidelines. Learners should critically assess the presented information, and draw conclusions only after careful consideration of all available scientific information.

For technical support, please email: support@purecme.com.

Instructors